BSE filing, NSE: CITIPOR. Summary written from the filing by ALFA Finder's alert engine.
Citi Port Financial Services Ltd: key numbers
- Share price
- ₹40.80
- Market cap
- ₹12.65 Cr
- Revenue (annual)
- ₹0.78 Cr
- Net profit (annual)
- ₹0.31 Cr
- P/E (TTM)
- 48.5×Sector 19.7×
- Promoter holding
- 29.01%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Citi Port Financial Services Ltd
All →Citi Port Financial Services Q2 FY27 Results: Net Profit ₹0 Cr
Citi Port Financial Services Ltd reported revenue from operations of ₹0.2 Cr (+0.0% YoY) and net profit of ₹0 Cr for Q2 FY27.
- Key figure
- Net profit ₹0 Cr
Citi Port Financial Services Board Meeting Date
Citi Port Financial Services Ltd has scheduled a board meeting on October 16, 2026, to consider and approve its unaudited financial results for the second quarter.
Citi Port Financial Services Annual General Meeting
Citi Port Financial Services Ltd held its 34th Annual General Meeting on 30th September 2026. The meeting approved the audited financial statements and director re-appointments.
Citi Port Financial Services Annual General Meeting
Citi Port Financial Services Ltd has scheduled its 34th Annual General Meeting for September 30, 2026, in Hyderabad to transact ordinary and special business.
Citi Port Financial Services Annual Report
Citi Port Financial Services Ltd has submitted its 34th Annual Report for the financial year 2025-26, along with the notice for the upcoming Annual General Meeting.
Citi Port Financial Services Management Change
Citi Port Financial Services Limited has appointed Mr. Narendra Babu Gutta as a Non-Executive Independent Director, effective August 22, 2026, for a five-year term.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.